Karen Heim

Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board. Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations. Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incentivizing research and development activities in Canada. Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.